Access to Medicines

Pharma’s alleged “breakthrough” position at Pandemic Treaty Negotiations is a sham 

Access to Medicines

Challenging Dr. Tedros’ Breathtakingly Bad Statement Supporting Intellectual Property and its “Mea... 

Access to Medicines

Pharma Pricing Secrecy Runs Amok 

Access to Medicines

U.S. Torpedoes Extension of WTO TRIPS Decision to Include Tests and Treatments and Hides Behind the Façade of... 

Access to Medicines

Switzerland and Mexico’s Communication to the TRIPS Council is Replete with Disinformation and Their Que... 

Access to Medicines

Bad Faith from Big Pharma, Rich Countries and the WTO Poison WTO TRIPS Waiver Negotiations 

Access to Medicines

Time to Walk Away from the WTO Proposed Text 

Access to Medicines

The Quad TRIPS Waiver Text is not a Compromise; It is an Abomination 

Access to Medicines

Moderna’s Global Public Health Strategy:  Parsing the Hype and Shameful Access Gaps 

Access to Medicines

Merck’s Molnupiravir – Overcoming impending barriers to affordable global access 

Access to Medicines

Biggest Roadblock to Biden-Convened COVID-19 Summit’s Success: Fealty to Moderna and Pfizer 

Access to Medicines

Biden’s $2.7 billion investment in supply chains is a cynical boost to Big Pharma’s continued control over... 

Access to Medicines

The European Union, Led by Germany’s Chancellor Merkel, Chokes Off Progress on Intellectual Property Waiver ... 

Access to Medicines

Disinformation, Diversion, and Delay: The Real Text of the European Union’s Communication to the WTO TRIPS C... 

Access to Medicines

The Impracticality of Relying on Compulsory Licenses to Expand Production Capacity for COVID-19 Vaccines 

SEE MORE